<SEC-DOCUMENT>0001656472-20-000086.txt : 20200916
<SEC-HEADER>0001656472-20-000086.hdr.sgml : 20200916
<ACCEPTANCE-DATETIME>20200916184501
ACCESSION NUMBER:		0001656472-20-000086
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20200915
FILED AS OF DATE:		20200916
DATE AS OF CHANGE:		20200916

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			GORENSTEIN MICHAEL RYAN
		CENTRAL INDEX KEY:			0001797199

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38403
		FILM NUMBER:		201179707

	MAIL ADDRESS:	
		STREET 1:		111 PETER STREET, SUITE 300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2G9

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cronos Group Inc.
		CENTRAL INDEX KEY:			0001656472
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		111 PETER STREET
		STREET 2:		SUITE 300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2G9
		BUSINESS PHONE:		(416) 504-0004

	MAIL ADDRESS:	
		STREET 1:		111 PETER STREET
		STREET 2:		SUITE 300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2G9

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PharmaCan Capital Corp.
		DATE OF NAME CHANGE:	20151021
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wf-form4_160029628806998.xml
<DESCRIPTION>FORM 4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2020-09-15</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001656472</issuerCik>
        <issuerName>Cronos Group Inc.</issuerName>
        <issuerTradingSymbol>CRON</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001797199</rptOwnerCik>
            <rptOwnerName>GORENSTEIN MICHAEL RYAN</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>111 PETER STREET, SUITE 300</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>TORONTO</rptOwnerCity>
            <rptOwnerState>A6</rptOwnerState>
            <rptOwnerZipCode>M5V 2G9</rptOwnerZipCode>
            <rptOwnerStateDescription>ONTARIO, CANADA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Executive Chairman</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>COMMON SHARES</value>
            </securityTitle>
            <transactionDate>
                <value>2020-09-15</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>M</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>645555</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0.2353</value>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1935005</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>COMMON SHARES</value>
            </securityTitle>
            <transactionDate>
                <value>2020-09-15</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>F</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F2"/>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>28108</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>5.40</value>
                    <footnoteId id="F3"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1906897</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>WARRANTS</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0.2353</value>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2020-09-15</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>M</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>645555</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F4"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F4"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>COMMON SHARES</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>645555.0</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>0</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The price reported was converted from the Canadian exercise price of C$0.31 to U.S. dollars using an exchange rate of C$1.00 to US$0.7591 as reported by Bloomberg as of September 14, 2020.</footnote>
        <footnote id="F2">On September 15, 2020, the reporting person exercised warrants to purchase 645,555 common shares of Cronos Group Inc. (the &quot;Company&quot;) for C$0.31 per common share.  The reporting person paid the exercise price on a cashless basis, resulting in the Company's withholding of 28,108 common shares to pay the exercise price and issuing to the reporting person the remaining  617,447 common shares.</footnote>
        <footnote id="F3">The price reported is in U.S. dollars based on the exchange rate of C$1.00 to US$0.7591 as reported by Bloomberg as of September 14, 2020.</footnote>
        <footnote id="F4">494,912 warrants were issued on October 8, 2015 and were immediately exercisable and expire on October 8, 2020.  150,643 warrants were issued on October 28, 2015 and were immediately exercisable and expire on October 28, 2020.</footnote>
    </footnotes>

    <remarks>Exhibit List: Exhibit 24 - Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Eileen Uy, as attorney-in-fact for Michael R. Gorenstein</signatureName>
        <signatureDate>2020-09-16</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>a200914gorensteincronossec.htm
<DESCRIPTION>POA
<TEXT>
<!-- Document created using Workiva -->
<html>
<body>
<pre>
Michael Ryan Gorenstein  Exhibit 24


Authorization and Designation
to Sign and File
Section 16 Reporting Forms



    The undersigned, an executive officer and director of Cronos Group Inc., a
corporation incorporated under the British Columbia Business Corporations Act (the
"Company"), does hereby authorize and designate Jerry Barbato, Xiu Ming Shum or
Eileen Uy, each with right to substitute and resubstitute, but for only so long as each of
them is an officer of the Company, to sign and file on his or her behalf the application for
the required Securities and Exchange Commission ("SEC") electronic CIK/CCC codes
and any and all Forms 3, 4 and 5 and Forms 144 relating to equity securities of the
Company with the SEC pursuant to the requirements of Section 16 of the Securities
Exchange Act of 1934 ("Section 16") and Rule 144 under the Securities Act of 1933, as
amended.  This authorization, unless earlier revoked in writing, shall be valid until the
undersigned's reporting obligations under Section 16 and Rule 144 with respect to equity
securities of the Company shall cease.  All prior such authorizations are hereby revoked.

    IN WITNESS WHEREOF, the undersigned has executed this Authorization and
Designation this 14th day of September, 2020.




                            /s/ Michael Ryan Gorenstein
                            Michael Ryan Gorenstein


</pre>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
